David H. Munn

40.3k total citations · 16 hit papers
224 papers, 30.9k citations indexed

About

David H. Munn is a scholar working on Immunology, Biological Psychiatry and Oncology. According to data from OpenAlex, David H. Munn has authored 224 papers receiving a total of 30.9k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Immunology, 95 papers in Biological Psychiatry and 56 papers in Oncology. Recurrent topics in David H. Munn's work include Tryptophan and brain disorders (95 papers), Immune Cell Function and Interaction (81 papers) and Immunotherapy and Immune Responses (44 papers). David H. Munn is often cited by papers focused on Tryptophan and brain disorders (95 papers), Immune Cell Function and Interaction (81 papers) and Immunotherapy and Immune Responses (44 papers). David H. Munn collaborates with scholars based in United States, Japan and China. David H. Munn's co-authors include Andrew L. Mellor, Phillip Chandler, Madhav Sharma, Babak Baban, John T. Attwood, I. E. Bondarev, Bruce R. Blazar, Brendan Marshall, Jeffrey R. Lee and Min Zhou and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David H. Munn

221 papers receiving 30.5k citations

Hit Papers

Prevention of Allogeneic Fetal Rejection by Tryptophan Ca... 1998 2026 2007 2016 1998 2004 2014 1999 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
    1998 2.0k citations David H. Munn, Brendan Marshall et al. profile →
  2. Ido expression by dendritic cells: tolerance and tryptophan catabolism
    2004 1.9k citations Andrew L. Mellor, David H. Munn profile →
  3. Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
    2014 1.8k citations Nagendra Singh, Huidong Shi et al. Immunity profile →
  4. Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism
    1999 1.3k citations David H. Munn, Andrew L. Mellor et al. profile →
  5. GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase
    2005 974 citations David H. Munn, Madhav Sharma et al. Immunity profile →
  6. Indoleamine 2,3-dioxygenase and tumor-induced tolerance
    2007 853 citations David H. Munn, Andrew L. Mellor profile →
  7. Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
    2002 814 citations David H. Munn, Madhav Sharma et al. profile →
  8. IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
    2016 798 citations David H. Munn, Andrew L. Mellor profile →
  9. Indoleamine 2,3 dioxygenase and metabolic control of immune responses
    2012 795 citations David H. Munn, Andrew L. Mellor profile →
  10. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
    2004 700 citations David H. Munn, Madhav Sharma et al. profile →
  11. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
    2007 652 citations Madhav Sharma, Babak Baban et al. profile →
  12. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
    2011 532 citations Qing Zhou, Meghan E. Munger et al. Blood profile →
  13. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
    2013 522 citations David H. Munn et al. profile →
  14. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
    1999 519 citations Andrew L. Mellor, David H. Munn profile →
  15. Immune suppressive mechanisms in the tumor microenvironment
    2015 408 citations David H. Munn et al. profile →
  16. Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
    2015 371 citations David H. Munn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Munn United States 84 17.1k 9.4k 7.4k 7.3k 3.8k 224 30.9k
Andrew L. Mellor United States 82 16.3k 1.0× 10.4k 1.1× 7.2k 1.0× 5.3k 0.7× 4.4k 1.2× 228 31.1k
Francesca Fallarino Italy 64 8.8k 0.5× 4.9k 0.5× 4.8k 0.7× 2.5k 0.3× 2.0k 0.5× 176 17.8k
Paolo Puccetti Italy 78 10.8k 0.6× 4.6k 0.5× 4.7k 0.6× 2.4k 0.3× 1.9k 0.5× 255 21.4k
Ursula Grohmann Italy 53 6.8k 0.4× 3.9k 0.4× 2.4k 0.3× 1.6k 0.2× 1.8k 0.5× 130 11.9k
Miriam Mérad United States 95 27.5k 1.6× 1.3k 0.1× 11.6k 1.6× 8.3k 1.1× 709 0.2× 248 46.1k
Stefan Rose‐John Germany 109 18.4k 1.1× 963 0.1× 13.7k 1.8× 17.4k 2.4× 827 0.2× 564 47.9k
Burkhard Becher Switzerland 80 15.3k 0.9× 1.4k 0.1× 6.2k 0.8× 3.8k 0.5× 366 0.1× 234 27.0k
Ronald L. Wilder United States 47 5.9k 0.3× 487 0.1× 3.8k 0.5× 2.5k 0.3× 1.6k 0.4× 113 27.1k
Iain L. Campbell United States 76 6.8k 0.4× 882 0.1× 4.0k 0.5× 2.5k 0.3× 593 0.2× 314 17.9k
Etty Benveniste United States 80 7.5k 0.4× 716 0.1× 6.0k 0.8× 3.8k 0.5× 402 0.1× 233 18.5k

Countries citing papers authored by David H. Munn

Since Specialization
Citations

This map shows the geographic impact of David H. Munn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Munn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Munn more than expected).

Fields of papers citing papers by David H. Munn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Munn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Munn. The network helps show where David H. Munn may publish in the future.

Co-authorship network of co-authors of David H. Munn

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Munn. A scholar is included among the top collaborators of David H. Munn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Munn. David H. Munn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kyritsi, Konstantina, Rafał Pacholczyk, Eugene F. Douglass, et al.. (2025). β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapy. Journal for ImmunoTherapy of Cancer. 13(4). e011322–e011322. 1 indexed citations
2.
Kumar, Kunal, Huidong Shi, Huabin Zhu, et al.. (2025). UFL1 promotes survival and function of virtual memory CD8 T cells. The Journal of Immunology. 214(3). 446–459.
3.
Thomas, Beena, William Pilcher, Lori Ponder, et al.. (2023). The Simple prEservatioN of Single cElls method for cryopreservation enables the generation of single-cell immune profiles from whole blood. Frontiers in Immunology. 14. 1271800–1271800. 4 indexed citations
4.
Aboelella, Nada S., Zhi‐Chun Ding, Hongyan Xu, et al.. (2022). Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy. Journal for ImmunoTherapy of Cancer. 10(7). e004938–e004938. 10 indexed citations
5.
Sharma, Madhav, Rafał Pacholczyk, Huidong Shi, et al.. (2021). Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity. Immunity. 54(10). 2354–2371.e8. 56 indexed citations
6.
Yu, Miao, Gang Guo, Lei Huang, et al.. (2020). CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nature Communications. 11(1). 515–515. 141 indexed citations
7.
Ding, Zhi-Chun, Huidong Shi, Nada S. Aboelella, et al.. (2020). Persistent STAT5 activation reprograms the epigenetic landscape in CD4 + T cells to drive polyfunctionality and antitumor immunity. Science Immunology. 5(52). 50 indexed citations
8.
Thangavelu, Govindarajan, Yu‐Chi Lee, Michaël Loschi, et al.. (2019). Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. The Journal of Immunology. 202(9). 2795–2805. 11 indexed citations
9.
Cao, Yu, Jimena Trillo-Tinoco, Rosa A. Sierra, et al.. (2019). ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature Communications. 10(1). 1280–1280. 111 indexed citations
10.
Lemos, Henrique, Eslam Mohamed, Lei Huang, et al.. (2016). STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation. Cancer Research. 76(8). 2076–2081. 251 indexed citations
11.
Yuan, Hong, Indumathi Manoharan, Amol Suryawanshi, et al.. (2015). β-Catenin Promotes Regulatory T-cell Responses in Tumors by Inducing Vitamin A Metabolism in Dendritic Cells. Cancer Research. 75(4). 656–665. 100 indexed citations
12.
Ravishankar, Buvana, Rahul Shinde, Haiyun Liu, et al.. (2014). Marginal zone CD169 + macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proceedings of the National Academy of Sciences. 111(11). 4215–4220. 91 indexed citations
13.
Ding, Zhi-Chun, Xiaoyun Lu, Miao Yu, et al.. (2014). Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1–PD-L1 Axis. Cancer Research. 74(13). 3441–3453. 109 indexed citations
14.
Binder, David C., Boris Engels, Ainhoa Arina, et al.. (2013). Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer. Cancer Immunology Research. 1(2). 123–133. 65 indexed citations
15.
Ravishankar, Buvana, Haiyun Liu, Rahul Shinde, et al.. (2012). Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. Proceedings of the National Academy of Sciences. 109(10). 3909–3914. 162 indexed citations
16.
Zhou, Qing, Meghan E. Munger, Steven L. Highfill, et al.. (2010). Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood. 116(14). 2484–2493. 230 indexed citations
17.
Metz, Richard, James B. DuHadaway, Sonja Rust, et al.. (2010). Zinc Protoporphyrin IX Stimulates Tumor Immunity by Disrupting the Immunosuppressive Enzyme Indoleamine 2,3-Dioxygenase. Molecular Cancer Therapeutics. 9(6). 1864–1871. 27 indexed citations
18.
Muller, Alexander J., Madhav Sharma, James B. DuHadaway, et al.. (2007). Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses. Cancer Research. 67(2). 792–801. 467 indexed citations
19.
Seymour, Robert L., Vadivel Ganapathy, Andrew L. Mellor, & David H. Munn. (2006). A high-affinity, tryptophan-selective amino acid transport system in human macrophages. Journal of Leukocyte Biology. 80(6). 1320–1327. 57 indexed citations
20.
Keskin, Derin B., Brendan Marshall, David H. Munn, Andrew L. Mellor, & Debra A. Gearhart. (2006). Decreased protein nitration in macrophages that overexpress indoleamine 2, 3-dioxygenase. Cellular & Molecular Biology Letters. 12(1). 82–102. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew L. Mellor Breakdown of academic impact, for papers by Francesca Fallarino Breakdown of academic impact, for papers by Paolo Puccetti Breakdown of academic impact, for papers by Ursula Grohmann Breakdown of academic impact, for papers by Miriam Mérad Breakdown of academic impact, for papers by Stefan Rose‐John Breakdown of academic impact, for papers by Burkhard Becher Breakdown of academic impact, for papers by Ronald L. Wilder Breakdown of academic impact, for papers by Iain L. Campbell Breakdown of academic impact, for papers by Etty Benveniste
Rankless by CCL
2026